English 
Français 
Русский 
Español 
Deutsch 
Português 
العربية 
Italiano News
News about ozelle
Events & Activities
Ozelle Shenzhen Office Officially Opens
With deep expertise in medical diagnostics, Ozelle is dedicated to delivering innovative and high-precision solutions. From our headquarters in Germany, we are steadily building a global strategic presence. China plays a vital role as our core manufacturing base, enabling efficient, stable, and highquality supply chain support for global delivery. The launch of our Shenzhen Office
Ozelle shines at Medlab Middle East 2025, showcasing cutting-edge AI-Powered POCT solutions
On February 6th, Medlab Middle East 2025 concluded successfully at the Dubai World Trade Center. As one of the most influential medical laboratory exhibitions in the Middle East and North Africa region, the event attracted a vast number of professional visitors and leading enterprises from all around the world. During this event, Ozelle stood out by presenting an impressive range of AI-Powered diagnostic solutions, demonstrating its
We are attending Medi Pharm Expo Vietnam 2024
The 22nd International Medical, Hospital and Pharmaceutical Exhibition – VIETNAM MEDI-PHARM EXPO 2024, under the support and sponsorship of the Ministry of Health of Vietnam, took place at the Saigon Exhibition and Convention Center (SECC) – 799 Nguyen Van Linh, Tan Phu Ward, Dist 7, HCMC, Viet Nam during 3 days, from 1st to 3rd
Latest News
Unlock a new era in blood diagnostics with Ozelle’s EHBT-75 Analyzer
Ozelle proudly introduces EHBT-75, a revolutionary 7-Diff Auto Hematology Analyzer designed to empower clinical healthcare with AI-driven precision, delivering deeper, clearer insights than ever before. Why EHBT-75? • AI-driven accuracy: Advanced deep learning precisely identifies and classifies cells. • Superior imaging: High-resolution image-based analysis provides detailed cellular morphology. • Breakthrough staining technology: Liquid-based staining
FDA-Clearance for HemoScreen Direct Capillary Sampling
This recent FDA clearance has finally brought HemoScreen to its full potential as a true POC hematology analyzer with its proprietary single-use reagent cartridge, automatic sample preparation, and exceptionally simple blood collection procedure. FDA Clearance HemoScreen has been FDA-cleared since 2018 as a moderately complex point-of-care hematology system, and is to date, the only 5-part diff CBC
Reducing Emergency Department Wait Times with Point-of-Care CBC Testing
Emergency departments today are at a breaking point. With patient volumes climbing and staff stretched thin, long wait times have become the norm rather than the exception. Among the many bottlenecks in ED workflows, delays in laboratory test results, especially Complete Blood Counts (CBCs), can significantly slow down triage and treatment decisions. But what if
Knowledge popularization
CBC Analyzer Prices: How to Compare the Total Cost of Ownership
Investing in cutting-edge technology can seem costly at first glance, and often there’s more than the sticker cost to consider. When purchasing a CBC analyzer, it’s crucial that you look beyond the cost per test or the cost of the machine and instead calculate the total cost of ownership. So, what exactly can you expect with
Revolutionizing Healthcare Access on Pitcairn Islands with HemoScreen
Pitcairn Island, famously the most remote human settlement in the world, presents unique healthcare challenges. With a population of around 50 residents and located over 3,000 miles from the nearest hospital in New Zealand, Pitcairn faces significant hurdles in accessing quality and timely medical care. The island’s isolation means that healthcare providers must rely on
How Cutting-Edge Medical Devices Can Detect Sepsis Earlier
Of the 850,000 cases of sepsis diagnosed annually, as many as 80% start receiving treatment in the emergency department. Early detection and treatment may prevent progression to severe sepsis or septic shock while reducing the number of ICU admissions related to the dangerous bacterial bloodstream infection. The HemoScreen from PixCell Medical leverages a revolutionary
